| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.12 | 0.007 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.098 | 0.04 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.074 | 0.09 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.076 | 0.1 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.045 | 0.3 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.032 | 0.5 |